NEW YORK (360Dx) – BioAffinity Technologies on Wednesday announced it raised more than $4 million in Series A financing.

Company President and CEO Maria Zannes said in a statement that the financing will go toward the commercialization of its lung cancer diagnostic and further development of additional cancer tests and cancer therapeutics.